Market Access begins before launch. Fyrn defines access pathways early, aligning clinical value, commercial objectives and payer realities.
Fyrn delivers a full suite of market access and reimbursement services for pharmaceuticals, biotechnology, and medical devices. We combine strategic insight, evidence-based thinking, and practical solutions to help clients navigate complex healthcare systems and secure timely, sustainable patient access. Explore our service offerings to discover how we can support your product and portfolio objectives.
We provide strategic, evidence-led services supporting market access success across global healthcare systems.
We develop clear market access strategies enabling timely patient access across complex global healthcare systems.
We design sustainable pricing strategies aligned with value evidence, payer expectations, and long-term commercial objectives.
We support reimbursement planning to secure coverage decisions through evidence-driven engagement with payers and authorities.
We provide HTA strategy and submission support to strengthen value narratives and decision-making outcomes.
We craft compelling value propositions linking clinical outcomes, economic evidence, and stakeholder priorities across markets.
We support early and launch-phase planning to optimise access pathways and stakeholder engagement strategies.
We guide evidence strategies integrating clinical, economic, and real-world data to support access success.
Identify and prioritise key stakeholders, building engagement strategies that support market access and reimbursement goals.
Analyse healthcare policy landscapes to guide access strategy, compliance, and effective decision-making across markets.
Design economic models and cost-effectiveness analyses to strengthen product value propositions for payers.
Generate real-world data insights to support market access, HTA submissions, and reimbursement strategies.
Plan and implement early access initiatives to accelerate patient availability while meeting regulatory requirements.
Optimise product strategies across multiple indications and lifecycle stages to maintain access and commercial success.
Coordinate cross-functional launch activities ensuring timely market entry, stakeholder alignment, and payer readiness.
Deliver actionable insights on competitors, payer trends, and market dynamics to inform strategic decisions.
We follow a structured, evidence-led process to deliver clear, effective market access and reimbursement solutions.
Contact us to discuss your market access and reimbursement needs and explore tailored solutions for your products.
